HealthQuill Hong Kong
Britain’s GSK Plc will pay Jiangsu Hengrui Pharmaceuticals $500 million upfront to acquire global licensing rights for the Chinese company’s 12 potential medicines.
Drugs Health Pharma

GSK inks $500m deal with Jiangsu Hengrui for 12 potential medicines

HQ Team July 28, 2025: Britain’s GSK Plc will pay Jiangsu Hengrui Pharmaceuticals $500 million upfront to acquire global licensing rights for the.

Read More
US-based Vertex Pharmaceutical Inc. has signed a licensing pact with China’s Zai Lab Ltd. to develop and commercialise the Boston-headquartered company’s medicine, which is under trial, for treating chronic kidney diseases.
Drugs Health Pharma

Vertex, China’s Zai to develop, commercialise kidney disease drug

US-based Vertex Pharmaceutical Inc. has signed a licensing pact with China’s Zai Lab Ltd. to develop and commercialise the Boston-headquartered company’s medicine, which.

Read More
Authorities in Hong Kong culled all the pigs that tested positive for African swine fever in the Ta Kiu Ling farm, according to a government statement.
Climate Health Pharma

Hong Kong culls all pigs tested positive for African swine fever

Authorities in Hong Kong culled all the pigs that tested positive for African swine fever in the Ta Kiu Ling farm, according to.

Read More
fibrosis therapy pact
Health Pharma

2seventy bio, China’s JW Therapeutics sign pact for cancer therapy

2seventy bio, Inc., an immuno-oncology cell therapy company, and China’s JW Therapeutics, announced a pact to establish a platform to explore T cell-based.

Read More